CrushSCI.com
114.5平均天数
110中位天数
32最短天数
203最长天数
3912025发文量

Paper Review Records

全部论文审稿周期

15 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接

167 天

Real-world outcomes of asciminib versus first- and second-generation tyrosine kinase inhibitors as second-line treatment for chronic-phase chronic myeloid leukemia

作者
Ehab L. Atallah; Islam Sadek; Emily McGovern; Dominick Latremouille-Viau; Carmine Rossi; Remi Bellefleur; Nathan Gobeil; Gabriel Marquez; Annie Guérin; Daisy Yang; David Wei展开收起
作者单位
Medical College of Wisconsin, Milwaukee, United States; Novartis Pharmaceuticals Corporation, East Hanover, United States; Analysis Group, Inc., Montréal, Canada展开收起
PDF源文件 DOI 网页
203 天

Intensive induction chemotherapy in adult acute myeloid leukemia: A single centre assessment of complete remission and induction mortality

作者
Zoha Asghar; Nabiha Saeed; Muhammad Usman Shaikh展开收起
作者单位
Medical College, Aga Khan University, Stadium Road, Karachi, Pakistan; Department of Oncology, Aga Khan University Hospital, Stadium Road, Karachi, Pakistan; Department of Pathology, Laboratory Medicine and Oncology, Aga Khan University Hospital, Stadium Road, Karachi, Pakistan展开收起
PDF源文件 DOI 网页
35 天

Comparison allogeneic hematopoietic stem cell transplantation and chemotherapy for consolidation in acute lymphoblastic leukemia in a Colombian Cohort. A propensity score matching analysis

作者
Juan F. Combariza-Vallejo; Laura María Díaz-Correa展开收起
作者单位
Grupo de investigación INPAC, Colombia; Cancer and Hematology departament, Clinica Colsánitas SA, Clínica Universitaria Colombia, Bogotá, Colombia; Hematology department, Hospital Pablo Tobón Uribe, Medellín, Colombia展开收起
PDF源文件 DOI 网页
74 天

Age over sibling: Younger unrelated donors provide superior outcomes compared to sibling donors in fully matched HCT in older AML/MDS patients

作者
Witold Prejzner; Alicja Sadowska-Klasa; Johannes Lakner; Anastazja Szlauer-Stefańska; Anna Łojko-Dankowska; Maciej Majcherek; Ewa Karakulska-Prystupiuk; Patrycja Mensah-Glanowska; Anna Czyż; Christian Junghanss; Jan Maciej Zaucha展开收起
作者单位
Department of Hematology Transplantology and Cell Therapies, Medical University of Gdansk, Poland; Department of Hematology, Transplantology and Cell Therapies, University Clinical Center Gdańsk, Poland; Department of Internal Medicine — Clinic and Policlinic for Hematology, Hemostaseology, Oncology, Stem Cell Therapy and Palliative Medicine, Rostock University Medical Center, Rostock, Germany; Bone Marrow Transplantation and Oncohematology Department, Maria Sklodowska-Curie National Research Institute of Oncology (branch in Gliwice), Gliwice, Poland; Department of Hematology, Transplantation and Cell Therapy, Poznan University of Medical Sciences, Poland; Department and Clinic of Hematology, Cellular Therapies and Internal Medicine, Wroclaw Medical University, Wroclaw, Poland; Department of Hematology, Transplantation and Internal Medicine, Medical University of Warsaw, Poland; Department of Hematology, Jagiellonian University Collegium Medicum, University Hospital in Cracow, Kraków, Poland展开收起
PDF源文件 DOI 网页
119 天

Outpatient step-up dosing of teclistamab and talquetamab in relapsed or refractory

作者
Kunal Shah; Paul Forrest; Ananya Garg; Pranav Kolluru; David Kaminetzky; Gareth J. Morgan; Marc Braunstein; Oscar Lahoud; Faith E. Davies展开收起
作者单位
NYU Grossman School of Medicine, NYU Langone Health, New York, NY, USA; Center for Blood Cancers, Perlmutter Cancer Center, NYU Langone Health, New York, NY, USA展开收起
PDF源文件 DOI 网页
96 天

Readmission in patients with hematologic malignancies: A systematic review and meta-analysis

作者
Mingfeng Yang; Ya Li; Hui Ju; Jianhong Wang展开收起
作者单位
Department of Haematology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China展开收起
PDF源文件 DOI 网页

FAQ

LEUKEMIA RESEARCH审稿要多久?

截至2026-11-19,CrushSCI 收录了 LEUKEMIA RESEARCH 的 15 篇完整审稿记录。最快一篇从收稿到录用用了 32 天(Influence of IGF2BP3 on t(4;11) fusion mRNA and protein abundance,2026-06-26 收稿,2026-07-28 录用),最慢一篇用了 203 天;平均 114.5 天,中位数 110 天。

Expert Matching · Case Demo

把投稿要求,转成可验证的期刊方案

说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。

我们会在半小时内回复。

CrushSCI 在线

客户询问

我是环境工程专业,需要一篇 SCI,希望 3 个月内见刊。没有基金,也没有大牛挂名,可以投哪些期刊?

CrushSCI回复

可以。先按 90 天时限做可行性筛选,同步查找无基金、无知名作者挂靠的典型论文案例,作为选刊依据。重点核对研究质量与期刊 scope。

拟题建议
《融合机器学习与生命周期评价的城市污水处理碳排放预测与优化》

样本口径2026 年最近 5 篇有效论文样本

平均审稿59.6 天

中位数65 天

Contact CrushSCI

联系 CrushSCI

留下手机号或微信号,我们将与你确认学术润色、结构优化或一对一辅导咨询需求。

我们会在半小时内回复。

当前选择:学术咨询服务

预留联系方式

也可以直接发送邮件至 leader@crushsci.com

手机号和微信号至少填写一项,仅用于本次咨询联系,不会公开。